Enzalutamide

Pfizer and Astellas report positive data from prostate cancer therapy trial
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Pfizer
Astellas
prostate cancer
clinical trials
Enzalutamide
leuprolide
Flag link:
Can Pharma Influence Physician Prescribing? Unleashing New Data Using Prostate Cancer Drugs
Can Pharma Influence Physician Prescribing? Unleashing New Data Using Prostate Cancer Drugs
Forbes
physicians
prostate cancer
abiraterone
Enzalutamide
physician payments
Flag link:
Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer
Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer
Yahoo/MarketWired
Enzalutamide
Medivation
Astellas
breast cancer
Flag link:
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
Yahoo/BusinessWire
Enzalutamide
prostate cancer
metastatic prostate cancer
Xtandi
Astellas
Flag link:
Medivation, Astellas prostate cancer drug meets trial goals
Medivation, Astellas prostate cancer drug meets trial goals
Yahoo/Reuters
Medivation
prostate cancer
Astellas
Enzalutamide
Flag link:
Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Breast Cancer Patients
Yahoo
Medivation
Astellas
Enzalutamide
breast cancer
Flag link:
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Yahoo/BusinessWire
Astellas
Medivation
Enzalutamide
prostate
Flag link:
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Yahoo/MarketWire
Astellas
Medivation
Enzalutamide
prostate cancer
Flag link:
Decision Date for Medivation Drug
Decision Date for Medivation Drug
Yahoo/Zacks
Medivation
Astellas
Enzalutamide
prostate cancer
Flag link:
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
Yahoo/MarketWire
Medivation
Astellas
Enzalutamide
prostate cancer
Flag link:
Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA
Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA
Yahoo/Fly on the Wall
Enzalutamide
Medivation
Astellas
prostate cancer
Flag link:
Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A
Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A
Bloomberg
prostate cancer
Medivation
M&A
AbbVie
Astellas
Enzalutamide
Flag link:
Medivation Files Enzalutamide NDA
Medivation Files Enzalutamide NDA
Yahoo/Zacks
Medivation
Astellas
prostate cancer
Enzalutamide
Flag link:
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Flag link:
Top 10 late-stage cancer drugs in 2012
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Flag link: